BDP-13176
CAS No. 2290660-61-4
BDP-13176 ( —— )
Catalog No. M24042 CAS No. 2290660-61-4
BDP-13176 is a potent?inhibitor of fascin 1(Kd?of 90 nM and an?IC50?of 240 nM). It has potential as an anti-metastatic agent.
Purity : >98% (HPLC)
COA
Datasheet
HNMR
HPLC
MSDS
Handing Instructions
Size | Price / USD | Stock | Quantity |
5MG | 201 | In Stock |
|
10MG | 323 | In Stock |
|
25MG | 552 | In Stock |
|
50MG | 785 | In Stock |
|
100MG | 1062 | In Stock |
|
500MG | 2142 | In Stock |
|
1G | Get Quote | In Stock |
|
Biological Information
-
Product NameBDP-13176
-
NoteResearch use only, not for human use.
-
Brief DescriptionBDP-13176 is a potent?inhibitor of fascin 1(Kd?of 90 nM and an?IC50?of 240 nM). It has potential as an anti-metastatic agent.
-
DescriptionBDP-13176 is a potent?inhibitor of fascin 1(Kd?of 90 nM and an?IC50?of 240 nM). It has potential as an anti-metastatic agent.
-
Synonyms——
-
PathwayOthers
-
TargetOther Targets
-
Recptorfascin 1
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number2290660-61-4
-
Formula Weight497.4
-
Molecular FormulaC24H22Cl2N6O2
-
Purity>98% (HPLC)
-
SolubilityDMSO:125 mg/mL (251.32 mM; Need ultrasonic)
-
SMILESO=C(NC1=CC=NC=C1)C(C2=C3C=NN2C4CCNCC4)=CN(CC5=CC=C(Cl)C(Cl)=C5)C3=O
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference
1.Francis S, et al. Structure-based design, synthesis and biological evaluation of a novel series of isoquinolone and pyrazolo[4,3-c]pyridine inhibitors of fascin 1 as potential anti-metastatic agents. Bioorg Med Chem Lett. 2019;29(8):1023-1029.
molnova catalog
related products
-
2-Iodobenzoic acid
2-Iodobenzoic acid is the impact-sensitive intermediate in the synthesis of the Dess-Martin periodinane.
-
Thymulin
Thymulin is a peptide hormone which is mainly produced by thymic epithelial cells and it has immune-modulatory and anti-inflammatory effects.
-
Bonducellin
Bonducellin has anti-inflammatory activities, it can significantly and dose-dependently inhibit the inflammatory mediators; nitric oxide (NO), and cytokines [tumor necrosis factor (TNF)-alpha and interleukin (IL)-12.